Clinical congestion is the main driver of heart failure (HF) decomposition and hospitalization. The combined assessment of congestion status at admission, through clinical examination, echocardiography and lung ultrasound, should be used to better recognize the type and the site of congestion. Different congestion locations may be related to a different outcome. The study evaluated: 1) Cardiac, pulmonary and systematic congestion occurrence in heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF); 2) The prognostic role of different congestion (Cardiac vs. Pulmonary vs. Systematic in terms of cardiovascular death or re-hospitalization during 6-month of follow up). Multi-centre, Observational study was implemented, including patients with the diagnosis of acute heart failure (AHF) according to the recent HF guidelines. A total of 230 patients with AHF (135 HFrEF and 95 HFpEF) were included in the analysis. Systemic congestion was significantly prevalent In HFrEF with respect to HFpEF due to the evidence of increased ICV size (22 ± 5 vs. 17 ± 4 mm; p ≤ 0.05) and a lower rate of reduced IVC collapse in HFrEF compared with HFpEF (47% vs 32%; p ≤ 0.01). Congestion status was different between HFrEF and HFpEF patients. The systemic congestion was related to poorer outcomes. There is a linear trend among single, double and triple congestion sites and increased risk for adverse events. Further studies should investigate what the best decongestion strategy by serial and qualitative measurement of congestion localization in AHF is.
Cite this paper
Nyagori, H. E. (2022). Prognostic Role of Cardiac, Pulmonary and Systematic Congestion in Patients Hospitalized for Acute Heart Failure. Open Access Library Journal, 9, e8983. doi: http://dx.doi.org/10.4236/oalib.1108983.
Shigeyama, J., Yasumura, Y., Sakamoto, A., et al. (2005) Increased Gene Expression of Collagen Types I and III is Inhibited by Beta-Receptor Blockade in Patients with Dilated Cardiomyopathy, European Heart Journal, 26, 2698-2705.
https://doi.org/10.1093/eurheartj/ehi492
Tsutsui, H., Matsushima, S., Kinugawa, S., et al. (2007) Angiotensin II Type 1 Receptor Blocker Attenuates Myocardial Remodeling and Preserves Diastolic Function in Diabetic Heart, Hypertension Research, 30, 439-449.
https://doi.org/10.1291/hypres.30.439
National Clinical Guideline Centre (UK) (2010) Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. Royal College of Physicians (UK), London, 34-47.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 310 Diseases and Injuries, 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015. The Lancet, 388, 1545-1602.
https://doi.org/10.1016/S0140-6736(16)31678-6
Ewald, B., Ewald, D., Thakkinstian, A. and Attia, J. (2008) Meta-Analysis of B Type Natriuretic Peptide and N-Terminal Pro B Natriuretic Peptide in the Diagnosis of Clinical Heart Failure and Population Screening for Left Ventricular Systolic Dysfunction. Internal Medicine Journal, 38, 101-113.
https://doi.org/10.1111/j.1445-5994.2007.01454.x
Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation, 112, e154-235.
https://doi.org/10.1161/CIRCULATIONAHA.105.167586
Kuck, K.-H., Bordachar, P., Borggrefe, M., Boriani, G., Burri, H., Leyva, F., et al. (2014) New Devices in Heart Failure: An European Heart Rhythm Association Report: Developed by the European Heart Rhythm Association; Endorsed by the Heart Failure Association. Europace, 16, 109-128.
https://doi.org/10.1093/europace/eut311
Bashi, N., Karunanithi, M., Fatehi, F., Ding, H. and Walters, D. (2017) Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews. Journal of Medical Internet Research, 19, e18. https://doi.org/10.2196/jmir.6571
Solanki, P. (2015) Heart Failure in South Asian Population. In: Baliga, R. and Haas, G., Eds., Management of Heart Failure, Springer, London, 305-317.
https://doi.org/10.1007/978-1-4471-6657-3_16